Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$17.13 - $38.52 $24,307 - $54,659
1,419 Added 5.98%
25,136 $572,000
Q4 2022

Feb 13, 2023

BUY
$29.44 - $37.31 $171,988 - $217,965
5,842 Added 32.68%
23,717 $809,000
Q3 2022

Nov 10, 2022

BUY
$28.84 - $38.92 $2,134 - $2,880
74 Added 0.42%
17,875 $543,000
Q2 2022

Aug 12, 2022

SELL
$33.25 - $45.11 $42,194 - $57,244
-1,269 Reduced 6.65%
17,801 $662,000
Q1 2022

May 16, 2022

BUY
$40.68 - $49.72 $58,782 - $71,845
1,445 Added 8.2%
19,070 $865,000
Q4 2021

Feb 14, 2022

SELL
$43.21 - $57.6 $24,370 - $32,486
-564 Reduced 3.1%
17,625 $849,000
Q3 2021

Nov 12, 2021

SELL
$52.8 - $60.32 $106,497 - $121,665
-2,017 Reduced 9.98%
18,189 $1.01 Million
Q2 2021

Aug 16, 2021

BUY
$51.29 - $59.15 $237,729 - $274,160
4,635 Added 29.77%
20,206 $1.1 Million
Q1 2021

May 14, 2021

SELL
$42.18 - $56.07 $178,590 - $237,400
-4,234 Reduced 21.38%
15,571 $873,000
Q4 2020

Feb 12, 2021

BUY
$35.18 - $43.52 $193,032 - $238,794
5,487 Added 38.32%
19,805 $862,000
Q3 2020

Nov 13, 2020

SELL
$37.98 - $48.72 $22,901 - $29,378
-603 Reduced 4.04%
14,318 $556,000
Q2 2020

Aug 12, 2020

BUY
$31.07 - $44.74 $203,322 - $292,778
6,544 Added 78.12%
14,921 $645,000
Q1 2020

May 13, 2020

BUY
$22.46 - $42.24 $6,782 - $12,756
302 Added 3.74%
8,377 $279,000
Q4 2019

Feb 12, 2020

SELL
$39.01 - $47.51 $54,496 - $66,371
-1,397 Reduced 14.75%
8,075 $334,000
Q3 2019

Nov 12, 2019

SELL
$38.66 - $47.41 $11,404 - $13,985
-295 Reduced 3.02%
9,472 $433,000
Q2 2019

Aug 14, 2019

SELL
$38.23 - $47.43 $65,449 - $81,200
-1,712 Reduced 14.91%
9,767 $422,000
Q1 2019

May 14, 2019

SELL
$41.26 - $58.35 $542,197 - $766,777
-13,141 Reduced 53.38%
11,479 $499,000
Q4 2018

Feb 13, 2019

BUY
$44.93 - $73.38 $143,865 - $234,962
3,202 Added 14.95%
24,620 $1.16 Million
Q3 2018

Nov 13, 2018

BUY
$56.85 - $80.35 $179,248 - $253,343
3,153 Added 17.26%
21,418 $1.6 Million
Q2 2018

Aug 14, 2018

SELL
$35.85 - $57.05 $167,742 - $266,936
-4,679 Reduced 20.39%
18,265 $1.01 Million
Q1 2018

May 15, 2018

BUY
$27.0 - $38.5 $8,532 - $12,166
316 Added 1.4%
22,944 $872,000
Q4 2017

Feb 14, 2018

SELL
$28.0 - $33.2 $198,940 - $235,886
-7,105 Reduced 23.9%
22,628 $633,000
Q3 2017

Nov 14, 2017

BUY
$24.5 - $31.1 $220,279 - $279,620
8,991 Added 43.35%
29,733 $921,000
Q2 2017

Aug 14, 2017

BUY
N/A
20,742
20,742 $583,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $477M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.